Table 3.
Group | MDA (nmole/mg protein) |
Inhibition rate (%) | |
---|---|---|---|
A | Normal control | 1.69 ± 0.11 | |
| |||
In vitro | |||
B | FeCl2 | 2.63 ± 0.08** | |
C | FeCl2 + vitamin E (0.5 mM) | 0.76 ± 0.05## | 71.10 |
D | FeCl2 + JWXYS (0.1 mg/kg) | 2.10 ± 0.05## | 20.15 |
E | FeCl2 + JWXYS (1.0 mg/kg) | 1.44 ± 0.06## | 45.25 |
F | FeCl2 + JWXYS (10 mg/kg) | 1.27 ± 0.03### | 51.71 |
| |||
In vivo | |||
G | DMN | 3.71 ± 0.05** | |
H | DMN + vitamin E (0.69 mM) | 1.07 ± 0.05△△△ | 71.16 |
I | DMN + JWXYS (100 mg/kg) | 2.79 ± 0.05△△ | 24.80 |
J | DMN + JWXYS (300 mg/kg) | 2.21 ± 0.06△△ | 40.43 |
K | DMN + JWXYS (1000 mg/kg) | 1.15 ± 0.03△△△ | 69.00 |
Each value is presented as the mean ± SE (n = 6). Vitamin E was used as the positive control.
**P < 0.01, significantly different from Group A.
##,### P < 0.01 and 0.001, significantly different from Group B.
△△,△△△ P < 0.01 and 0.001, significantly different from Group G.
One-way analysis of variance coupled with Dunnett's test.
P values < 0.05 indicated significance.